Multiple myeloma (first line) - bortezomib and thalidomide: consultee and commentator comments on the ACD Multiple myeloma (first line) - bortezomib and thalidomide: manufacturer comments Multiple myeloma (first line) - bortezomib and thalidomide: patient and professional groups Multiple myeloma (first line) - bortezomib and thalidomide: commentator comments This page was last updated: 24 August 2010